Reuters logo
Teva says Israel probing same issues as U.S. bribery case
February 7, 2017 / 5:42 PM / in 9 months

Teva says Israel probing same issues as U.S. bribery case

JERUSALEM (Reuters) - Teva Pharmaceutical Industries (TEVA.TA) said on Tuesday that Israeli authorities were investigating the same issues as an earlier U.S. bribery settlement.

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun

“The company can confirm that, to the best of its knowledge, an investigation is being conducted in Israel regarding the same issues which led to a settlement with American justice authorities,” a spokesman said in a statement.

“The settlement referred to events that occurred between 2007-2012 and none of the people involved in the improper payments is currently employed at Teva,” the statement said.

Teva (TEVA.N) in December agreed to pay more than $519 million to settle U.S. criminal and civil allegations that the company bribed overseas officials to gain business for its medications.

Reporting by Ari Rabinovitch; Editing by Alexander Smith

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below